@article{ACS16923,
author = {Brandon E. Ferrell and Diana C. Jimenez and Danial Ahmad and Kabir Malkani and Jake L. Rosen and Gabriel Gaw and Konstadinos A. Plestis and T. Sloane Guy and H. Todd Massey and Vakhtang Tchantchaleishvili},
title = {Surgical ventricular reconstruction for ischemic cardiomyopathy—a systematic review and meta-analysis of 7,685 patients},
journal = {Annals of Cardiothoracic Surgery},
volume = {11},
number = {3},
year = {2022},
keywords = {},
abstract = {Background: Surgical ventricular reconstruction (SVR) has been used to control adverse ventricular remodeling and improve cardiac function in ischemic cardiomyopathy. The purpose of this systematic review and meta-analysis was to collect and analyze all available evidence on the utilization and efficacy of SVR.
Methods: An electronic database search was performed to identify all retrospective and prospective studies on SVR for ischemic cardiomyopathy in the English literature from 2000 through 2020. A total of 92 articles with a collective 7,685 patients undergoing SVR were included in the final analysis.
Results: The mean patient age was 61 years (95% CI: 59–63) and 80% (78–82%) were male. Congestive heart failure was present in 66% (54–78%) and angina in 58% (45–70%). Concomitant coronary artery bypass grafting was undertaken in 92% (90–93%) while 21% (18–24%) underwent mitral valve repair. Pre vs. post-SVR, significant improvement was seen in left ventricular ejection fraction (LVEF) [29.9% (28.8–31.2%) vs. 40.9% (39.4–42.4%), P},
issn = {2304-1021}, url = {https://www.annalscts.com/article/view/16923}
}